ADVERTISEMENT
ADVERTISEMENT

Enfermedad cardiovascular y diabetes

Silvio Schraier

Resumen


Según la Organización Mundial de la Salud (OMS), de los 57 millones de muertes globales/año, en el mundo, el 71% se debe a enfermedades no transmisibles y, dentro de ellas, más de la mitad a enfermedad cardiovascular. La hipertensión, el tabaquismo, la glucemia alta, la inactividad física, el sobrepeso y la obesidad, y los niveles altos de colesterol se encuentran entre los principales factores de riesgo de muerte a nivel mundial. La mayoría de estos factores se asocia con la incidencia de enfermedad cardiovascular (ECV) y diabetes mellitus (DM), y los pacientes con DM tienen una alta prevalencia de la mayoría de los factores de riesgo.


Palabras clave


Enfermedad cardiovascular; diabetes; factores de riesgo.

Texto completo:

PDF

Referencias


Narayan KM, Ali MK, Koplan JP. Global noncommunicable diseases–where worlds meet. N Engl J Med 2010; 363:196-1198.

Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation 2016; 133:187-225.

Zhang X, Devlin HM, Smith B, et al. Effect of lifestyle interventions on cardiovascular risk factors among adults without impaired glucose tolerance or diabetes: a systematic review and meta-analysis. PLoS One 2017; 12:e0176436.

Centers for Disease Control and Prevention. National diabetes statistics report, 2017. Atlanta (GA): Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services, 2017.

American Heart Association. My Life Check: Life’s Simple 7. American Heart Association Web site. Disponible en: http://mylifecheck.heart.org/. Accessed August 22, 2017.

Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation 2010; 121:586-613.

Rawshani A, Sattar N, Franzen S, et al. Relative prognostic importance and optimal levels of risk factors for mortality and cardiovascular outcomes in type 1 diabetes mellitus. Circulation 2019; 139(6):1900-1012.

Htay T, Soe K, López-Pérez A, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. Current Cardiology Reports; 2019:21:45.

Huxley RR, Peters SA, Mishra GD, et al. Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2015; 3:198-206.

Peters SA, Huxley RR, Woodward M, et al. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia 2014; 57:1542-51.

Gilbert RE, Krum H. Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy. Lancet. 2015 May 23; 385(9982):2107-17.

Perel C. Insuficiencia cardíaca y diabetes. Nuevos tratamientos para la diabetes. Insuficiencia Cardíaca 2018; 13(4):155-69.

Dunlay SM, Roger VL. Understanding the epidemic of heart failure: past, present, and future. Curr Heart Fail Rep 2014 Dec; 11(4):404-15.

Amato L, Paolisso G, Cacciatore F, Ferrara N, Ferrara P, Canonico S, Varricchio M, Rengo F. Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group. Diabetes Metab 1997 Jun; 23(3):213-8.




DOI: http://dx.doi.org/10.47196/diab.v54i2Sup.249

Copyright (c) 2020 Sociedad Argentina de Diabetes Asociación Civil

ADVERTISEMENT
ADVERTISEMENT